Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial.
Saved in:
| Title: | Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial. |
|---|---|
| Authors: | Mahar RK; Centre for Epidemiology, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Australia. robert.mahar@unimelb.edu.au.; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Australia. robert.mahar@unimelb.edu.au.; Methods and Implementation Support for Clinical Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia. robert.mahar@unimelb.edu.au., McGlothlin A; Berry Consultants, LLC, Austin, TX, USA., Dymock M; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, WA, Australia.; School of Population and Global Health, University of Western Australia, Perth, WA, Australia., Barina L; Department of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Bonten M; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; European Clinical Research Alliance On Infectious Diseases, Utrecht, the Netherlands., Bowen A; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, WA, Australia.; Perth Children's Hospital, Nedlands, WA, Australia., Cheng MP; Division of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Canada.; McGill University, Montreal, Canada., Daneman N; Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada., Goodman AL; MRC Clinical Trials Unit at University College London, London, UK.; Centre for Infection Diagnostics Research at King's College, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Lee TC; Division of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Canada., Lewis RJ; Berry Consultants, LLC, Austin, TX, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Lumley T; Department of Statistics, University of Auckland, Auckland, New Zealand., McLean ARD; Methods and Implementation Support for Clinical Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia., McQuilten Z; School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Alfred Health, Melbourne, Australia., Mora J; Department of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Paterson DL; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore., Price DJ; Centre for Epidemiology, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Australia.; Department of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Roberts J; Faculty of Medicine, University of Queensland Centre for Clinical Research, University of Queensland, Brisbane, Australia.; Herston Infectious Diseases Institute, Metro North Health, Brisbane, Australia.; Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia.; Division of Anaesthesiology, Critical Care, Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Montpellier, France., Snelling T; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, WA, Australia.; Department of Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Tverring J; Department of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.; Department of Clinical Sciences Helsingborg, Lund University, Lund, Sweden., Webb SA; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia., Yahav D; Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel., Davis JS; Infection Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Sydney, Australia.; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia., Tong SYC; Department of Infectious Diseases, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital, at the, Peter Doherty Institute for Infection and Immunity , Melbourne, Australia., Marsh JA; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, WA, Australia.; Medical School, Centre for Child Health Research, University of Western Australia, Perth, Australia. |
| Corporate Authors: | SNAP Global Trial Steering Committee |
| Source: | Trials [Trials] 2025 Feb 11; Vol. 26 (1), pp. 49. Date of Electronic Publication: 2025 Feb 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-024-08684-8 |
